简介:摘要:目的:观察分析依达拉奉治疗急性脑栓塞的临床治疗效果以及不良反应。方法:选取 2017 年我院脑病科收治的急性脑栓塞患者 120例作为此次研究的对象,随机分为观察组 60例和对照组 60例,对照组采用血栓通治疗,观察组在对照组基础上采用依达拉奉治疗,观察两组治疗效果和不良反应情况。结果:观察组总有效率明显高于对照组总有效率,观察组出现不良反应较少, P< 0.05,差异有统计学意义。结论:采取依达拉奉治疗急性脑栓塞,不但可以提高临床效果,并且安全性高,建议推广应用。
简介: 【摘要】 目的 观察银杏达莫联合阿司匹林共同治疗急性脑梗的临床治疗效果。方法 急性脑梗死的患者 120例, 随机分成对照组 60例和治疗组 60例, 对照组患者单独采用阿司匹林治疗, 治疗组患者在对照组患者的治疗基础上联合银杏达莫共同治疗, 观察两组患者治疗效果。结果 治疗组患者的治疗有效率 93.33%明显高于对照组患者 80.00%, 差异有统计学意义( P<0.05), 治疗组患者不良反应的发生率 6.67%明显低于对照组患者 26.67%, 差异有统计学意义( P<0.05)。结论 采用银杏达莫联合阿司匹林共同治疗急性脑梗, 效果明显, 不良反应发生率低, 受到患者及临床医生的认可, 具有较高的临床应用价值。 【关键词】 银杏达莫;阿司匹林;急性脑梗;临床治疗效果 [abstract] Objective To observe the clinical effect of Ginkgo biloba-damo combined with aspirin in the treatment of acute cerebral infarction. Methods 120 patients with acute cerebral infarction were randomly divided into control group (60 cases) and treatment group (60 cases). The patients in control group were treated with aspirin alone. The patients in treatment group were treated with Ginkgo biloba moxibustion combined with Ginkgo biloba moxibustion on the basis of the treatment of control group. Results The effective rate of the treatment group was 93.33% higher than that of the control group (80.00%, P < 0.05). The incidence of adverse reactions in the treatment group was 6.67% lower than that in the control group (26.67%, P < 0.05). Conclusion Ginkgo biloba Damo combined with aspirin in the treatment of acute cerebral infarction, the effect is obvious, the incidence of adverse reactions is low, approved by patients and clinicians, has a high clinical value.